Novel CD19/CD22 Bicistronic Chimeric Antigen Receptors Outperform Single or Bivalent Cars in Eradicating CD19+ CD22+, CD19-, and CD22- Pre-B Leukemia

被引：0
|
作者：
Qin, Haiying
Nguyen, Sang M.
Ramakrishna, Sneha
Tarun, Samiksha
Yang, Lila
Verdini, Nicholas Peter
Haso, Waleed
Fry, Terry J.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
810
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Activation of B lymphocytes: Integrating signals from CD19, CD22 and Fc gamma RIIb1
    Doody, GM
    Dempsey, PW
    Fearon, DT
    CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (03) : 378 - 382
  • [42] CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling
    Sato, S
    Jansen, PJ
    Tedder, TF
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) : 13158 - 13162
  • [43] B lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse
    Asano, N
    Fujimoto, M
    Yazawa, N
    Shirasawa, S
    Hasegawa, M
    Okochi, H
    Tamaki, K
    Tedder, TF
    Sato, S
    AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (02): : 641 - 650
  • [44] Tandem CD19/CD22 Dual Targets CAR-T Cells Therapy Obtains Superior CR Rate Than Single CD19 CAR-T Cells Infusion As Well As Sequential CD19 and CD22 CAR-T Cells Infusion for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients
    Liu, Sining
    Zhang, Xinyue
    Dai, Haiping
    Cui, Qingya
    Cui, Wei
    Yin, Jia
    Li, Zheng
    Xue, Shengli
    Yang, Chunxiu
    Yang, Xiao
    Qiu, Huiying
    Miao, Miao
    Chen, Suning
    Jin, Zhengming
    Fu, Chengcheng
    Li, Caixia
    Sun, Aining
    Han, Yue
    Wang, Ying
    Yu, Lei
    Wu, Depei
    Tang, Xiaowen
    BLOOD, 2021, 138
  • [45] Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphoma
    Roddie, Claire
    Lekakis, Lazaros J.
    Marzolini, Maria A. V.
    Ramakrishnan, Aravind
    Zhang, Yiyun
    Hu, Yanqing
    Peddareddigari, Vijay G. R.
    Khokhar, Nushmia
    Chen, Robert
    Basilico, Silvia
    Raymond, Meera
    Vargas, Frederick Arce
    Duffy, Kevin
    Brugger, Wolfram
    O'Reilly, Maeve A.
    Wood, Leigh
    Linch, David C.
    Peggs, Karl S.
    Bachier, Carlos
    Budde, Elizabeth Lihua
    Batlevi, Connie Lee
    Bartlett, Nancy
    Irvine, David
    Tholouli, Eleni
    Osborne, Wendy
    Ardeshna, Kirit M.
    Pule, Martin A.
    BLOOD, 2023, 141 (20) : 2470 - 2482
  • [46] Sequential treatment with anti-CD19 and CD22 chimeric antigen receptor T cells in children with relapsed or refractory B acute lymphoblastic leukemia
    Chanut, Mathilde
    HEMATOLOGIE, 2023, 29 (06): : 332 - 334
  • [47] CD19/CD22 Dual-Targeted CAR-TTherapy Active in Relapsed/Refractory DLBCL
    不详
    ONCOLOGIST, 2020, 25 : S12 - S13
  • [48] Double CD19/CD22 Chimeric Antigen Receptor-Modified T Cells for the Treatment of Stage IV Relapsed and Refractory Follicular Lymphoma
    Lai, Xun
    Gu, Xuezhong
    Tsao, Shih-Ting
    Zhang, Qin
    Liu, Yu-Chen
    Jiang Yaxian
    Yan, Li
    Chun, Jun
    Zhang, Rui
    Du, Yunyun
    Gao, Xiaoli
    Yang, Yingyu
    Qiu, Xiaolian
    Fang, Mingjing
    Wei, Song
    Chang, Lung-Ji
    BLOOD, 2017, 130
  • [49] CD22 CAR-T Induces Both CD19 and CD22 Surface Down-Modulation: Defining a Mechanism of Generalized Immune Evasion and the Effects of Epigenetic Modifiers
    Wang, Lingyan
    Zhang, Yue
    Anderson, Eden
    Kumar, Rajesh
    Lamble, Adam J.
    Orentas, Rimas J.
    BLOOD, 2020, 136
  • [50] CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations
    Aiyun Jin
    Jingjing Feng
    Guoqing Wei
    Wenjun Wu
    Luxin Yang
    Huijun Xu
    Yanlei Zhang
    Jiazhen Cui
    Alex Hongsheng Chang
    Yongxian Hu
    He Huang
    Bone Marrow Transplantation, 2020, 55 : 717 - 721
12345